Bessemer Group’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2K Hold
135
﹤0.01% 2344
2025
Q4
$3K Hold
135
﹤0.01% 2313
2025
Q3
$2K Hold
135
﹤0.01% 2283
2025
Q2
$2K Hold
135
﹤0.01% 2168
2025
Q1
$3K Sell
135
-10
-7% -$149 ﹤0.01% 2126
2024
Q4
$2K Hold
145
﹤0.01% 2179
2024
Q3
$2K Buy
+145
New +$1.37K ﹤0.01% 2154
2024
Q1
Sell
-4,642
Closed -$40K 2031
2023
Q4
$40K Hold
4,642
﹤0.01% 1369
2023
Q3
$32K Hold
4,642
﹤0.01% 1395
2023
Q2
$27K Hold
4,642
﹤0.01% 1473
2023
Q1
$30K Buy
+4,642
New +$44.3K ﹤0.01% 1314

Other funds holding ALHC

Bessemer Group's ALHC Position: Q1 2026 in Review

Bessemer Group held its Alignment Healthcare (ALHC) position steady in Q1 2026 at 135 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #2344.

Bessemer Group first reported a position in ALHC in Q1 2023 and has held it in 11 quarters since. The position peaked at $40K in Q4 2023. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

  • Bessemer Group held 135 shares of Alignment Healthcare worth $2K as of Q1 2026.
  • Bessemer Group left its Alignment Healthcare share count unchanged in Q1 2026.
  • Alignment Healthcare made up ﹤0.01% of Bessemer Group's portfolio in Q1 2026, its #2344 holding.
  • Bessemer Group first reported a position in Alignment Healthcare in Q1 2023 and has held it in 11 quarters since.
  • Bessemer Group's Alignment Healthcare position peaked at $40K in Q4 2023.
  • 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.